Dose Medical Corporation

Glaukos Corporation

Edwards Lifesciences Corporation

Atlas Copco Secoroc LLC

Via Medical Corporation

Epiroc Drilling Tools LLC

Kenneth Martin Curry

David S Haffner

Harold Alexander Heitzmann

Thomas W Burns

David Applegate

Mark L Jones

David K Wong

Jeffery T Ross

Bruce Nogales

James E Gharib

James R Petisce

Douglas Daniel Crimaldi

Henry Oviatt

Kyle E Johnson

Mena Valiket

William Tran

Luis Retana

Joelle Roche

Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allows for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.

Drug eluting ocular implants

Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.

Implants with controlled drug delivery features and methods of using same

A punctum plug or lacrimal insert is constructed of a monolithic material, such that the punctum plug is configured to turn approximately 90 degrees upon insertion into a canaliculus of an eye. The punctum plug or lacrimal insert may include high-molecular-weight polysaccharide and added plasticizers.

Materials and methods for punctal plugs

Controlled drug delivery ocular implants and methods of using same

Drug eluting ocular implant

Drug eluting ocular implants and methods of treating an ocular disorder

Drug eluting ocular implant and method of treating an ocular disorder

An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.

Intraocular physiological sensor

Disclosed herein are drug delivery punctal implants and methods of using the implants for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The physical arrangement of drugs within the punctal plugs disclosed herein results, in several embodiments, in advantageous controlled delivery of one or more drugs to the eye of a patient.

Punctal implants with controlled drug delivery features and methods of using same

An ocular implant configured for implantation into the eye of a subject comprising an elongate outer shell (), an internal plug () including a hydrogel and a drug reservoir including a drug () wherein the drug is configured to pass through at least a portion of the internal plug to control elution of the drug through the outer shell. The implant is made of biodegradable materials.

Bioresorbable ocular drug delivery device

Growing community of inventors

Oceanside, CA, United States of America

Kenneth Martin Curry